Position in JAZZ
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$3,469,968
+$199,403 QoQ
Shares Held
14,400
-16.8% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
2.02%
of 13F equity value
Holder Rank
#215
of 640 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Graphene Investments SAS holds $7,195,443 across 2 Biotechnology names. JAZZ ranks #2 (48.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,500 | $3,725,475 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
14,400 | $3,469,968 |
All Filings in JAZZ
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,469,968 | 14,400 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $3,270,565 | 17,300 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $2,941,000 | 17,300 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $3,532,240 | 26,800 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $2,844,016 | 26,800 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $2,557,490 | 20,600 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $2,980,230 | 24,200 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $3,008,070 | 27,000 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $3,351,322 | 31,400 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $3,094,794 | 25,700 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $2,755,200 | 22,400 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $2,899,456 | 22,400 | Shares | Sole | 2023-11-07 | |
| No filing history on record for this holder in this stock. | ||||||